ArticleAnnals of hematology2024
Targeting histone deacetylase 1 (HDAC1) in the bone marrow stromal cells revers imatinib resistance by modulating IL-6 in Ph + acute lymphoblastic leukemia.
Danna Wei et al.PubMed ↗Publisher ↗
No numbers read from the abstract.